Agile Therapeutics, Inc.
NASDAQ: AGRX Agile Therapeutics Anticipates Increased Growth In Q3 of 2022
EQS-News: Agile Therapeutics, Inc.
Contact DetailsMatt Riley – Head of Investor Relations & Corporate Communications Company Websitehttps://agiletherapeutics.com/ News Source: News Direct
21.10.2022 CET/CEST Dissemination of a Corporate News, transmitted by EQS News – a service of EQS Group AG. |
Language: | English |
Company: | Agile Therapeutics, Inc. |
United States | |
ISIN: | US00847L2097 |
EQS News ID: | 1469705 |
End of News | EQS News Service |